ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV (ARYD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ARYD · as of Jun 30, 2024
Ownership Breakdown
19
Institutional Holders
▼ 2 vs Q1
$26.86M
Total Inst. Value
▼ $5.31M vs Q1
7.54M
Shares Outstanding
freeFloat 43.79%
2.34M
13F Shares Held
▼ 518,402 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ARYD largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BERKLEY W R CORP biological products, (no diagnostic substances) | 319.5K | 4.10% | 4.10% | $3.66B | Aug 14, 2024 | — held |
GLAZER CAPITAL, LLC biological products, (no diagnostic substances) | 235.1K | 3.02% | 3.02% | $2.70B | Aug 14, 2024 | ▼ 97.5K |
FIR TREE CAPITAL MANAGEMENT LP biological products, (no diagnostic substances) | 230.6K | 2.96% | 2.96% | $2.64B | Aug 14, 2024 | ▲ 205.7K |
MIZUHO SECURITIES USA LLC biological products, (no diagnostic substances) | 208.8K | 2.68% | 2.68% | $2.37B | Jul 31, 2024 | ▼ 33.1K |
FARALLON CAPITAL MANAGEMENT LLC biological products, (no diagnostic substances) | 200.0K | 2.57% | 2.57% | $2.29B | Aug 14, 2024 | — held |
COWEN AND COMPANY, LLC biological products, (no diagnostic substances) | 174.3K | 2.24% | 2.24% | $2.00B | Aug 7, 2024 | ▼ 89.1K |
TENOR CAPITAL MANAGEMENT CO., L.P. biological products, (no diagnostic substances) | 150.0K | 1.93% | 1.93% | $1.72B | Aug 14, 2024 | — held |
HSBC HOLDINGS PLC biological products, (no diagnostic substances) | 149.9K | 1.93% | 1.93% | $1.72B | Aug 12, 2024 | — held |
AFFINITY ASSET ADVISORS, LLC biological products, (no diagnostic substances) | 133.5K | 1.72% | 1.72% | $1.53B | Aug 14, 2024 | — held |
RTW INVESTMENTS, LP biological products, (no diagnostic substances) | 128.0K | 1.64% | 1.64% | $1.47B | Aug 14, 2024 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
4
Increased
+218.3K shares1
New Positions
first time holders3
Decreased
−219.7K shares3
Sold Out
fully exitedNet shares change (top 50)
1.4K
+218.3K / −219.7K
Net new holders
-1
1 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ARYD insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
12
Sell transactions
0.00
Buy/Sell ratio
$13M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Stone Adam Leo Chief Executive Officer | Jul 31, 2024 | D-Return | 1,000,000 | — | — | 2.65M | Form 4 ↗ |
Stone Adam Leo Chief Executive Officer | Jul 31, 2024 | D-Return | 2,647,500 | — | — | 0 | Form 4 ↗ |
Stone Adam Leo Chief Executive Officer | Jul 31, 2024 | D-Return | 499,000 | $24.00 | $11.98M | 0 | Form 4 ↗ |
HENDERSON MICHAEL THOMAS director | Jul 31, 2024 | D-Return | 30,000 | — | — | 0 | Form 4 ↗ |
Trigg Leslie director | Jul 31, 2024 | D-Return | 30,000 | — | — | 0 | Form 4 ↗ |
Wider Todd director | Jul 31, 2024 | D-Return | 30,000 | — | — | 0 | Form 4 ↗ |
ARYA Sciences Holdings IV 10 percent owner | Jul 31, 2024 | D-Return | 1,000,000 | — | — | 2.65M | Form 4 ↗ |
ARYA Sciences Holdings IV 10 percent owner | Jul 31, 2024 | D-Return | 2,647,500 | — | — | 0 | Form 4 ↗ |
ARYA Sciences Holdings IV 10 percent owner | Jul 31, 2024 | D-Return | 499,000 | $24.00 | $11.98M | 0 | Form 4 ↗ |
ALTMAN MICHAEL SETH Chief Financial Officer | Jul 31, 2024 | D-Return | 1,000,000 | — | — | 2.65M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ARYA Sciences Acquisition Corp IV (ARYD) is primarily owned by institutional investors, who hold approximately 31.1% of total shares outstanding. Company insiders own approximately 56.21%, while retail and public investors account for the remaining 12.68%.
The largest institutional shareholder of ARYA Sciences Acquisition Corp IV is BERKLEY W R CORP, holding approximately 319,460 shares — equal to 4.10% of outstanding shares — as of June 30, 2024.
A total of 19 institutional investors currently hold ARYD stock, with a combined institutional value of approximately $26,858,128 as of the most recent 13F filing period.
Frequently asked questions
ARYD ownershipARYA Sciences Acquisition Corp IV (ARYD) is primarily owned by institutional investors, who hold approximately 31.1% of shares. The largest shareholder is BERKLEY W R CORP with a 4.10% stake. Company insiders hold 56.21%. Data sourced from SEC Form 13F as of June 30, 2024.